Highlights
NASDAQ: EGRX       Eagle Pharmaceutical
Last Price Today's Change   Day's Range   Trading Volume
88.00   -0.76 (0.86%)  87.86 - 89.50  136,782

Overview

Avg Volume (4 weeks):0
4 Weeks Range:80.65 - 91.07
52 Weeks Range:34.20 - 91.07
Average Price Target: 65.00
Price Target Upside/Downside: -23.00

Headlines



No recent Headlines for this stock.


Business Background

Eagle Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company focuses on developing and commercializing injectable products in the critical care and oncology areas. The Company's product portfolio includes products, including Argatroban; Ryanodex; docetaxel injection, non-alcohol formulation; and Bendeka. Its advanced candidates include EP-3101 (bendamustine Resistance Temperature Detectors (RTD)) (EP-3101), EP-4104 (dantrolene sodium for exertional heat stroke (EHS)) (EP-4104), EGL-4104-C-1702 (dantrolene sodium for drug induced hyperthermia), EP-5101 (pemetrexed) (EP-5101) and EGL-5385-C-1701 (fulvestrant). Its product portfolio focuses on oncology, critical care and orphan diseases. Bendamustine is an alkylating agent approved for use in chronic lymphocytic leukemia (CLL), and indolent B-cell non-Hodgkin's lymphoma (NHL), that has progressed during or within six months of treatment with rituximab or a rituximab-containing regimen.

  Be the first to like this.
 


 

4459  2643  565  656 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 BAC 24.215+0.585 
 JNUG 4.368-0.882 
 BABY 40.85+0.25 
 AKS 6.49-0.63 
 NUGT 8.06-1.30 
 SPY 238.79+1.62 
 GDX 22.115-1.085 
 ABX 17.083-1.957 
 FCX 12.915+0.685 
 XLF 23.965+0.285 
Partners & Brokers